Los Angeles Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Los Angeles Capital Management LLC

$24.7 Billion
Q3 2024

A detailed history of Los Angeles Capital Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 1,760 shares of REGN stock, worth $1.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,760

Previous 2,533 30.52%

Holding current value

$1.24 Million

Previous $2.66 Million 30.5%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$1024.09 - $1201.76 $791,621 - $928,960	-773 Reduced 30.52%	1,760 $1.85 Million
Q2 2024 Aug 05, 2024	BUY	$883.2 - $1071.19 $1.14 Million - $1.38 Million	1,290 Added 103.78%	2,533 $2.66 Million
Q1 2024 Apr 05, 2024	SELL	$902.69 - $993.35 $3.7 Million - $4.07 Million	-4,102 Reduced 76.74%	1,243 $1.2 Million
Q4 2023 Feb 06, 2024	BUY	$775.18 - $881.7 $3.6 Million - $4.1 Million	4,645 Added 663.57%	5,345 $4.69 Million
Q3 2023 Nov 06, 2023	BUY	$692.45 - $844.37 $101,790 - $124,122	147 Added 26.58%	700 $576,000
Q2 2023 Aug 03, 2023	SELL	$700.03 - $830.35 $27.1 Million - $32.1 Million	-38,693 Reduced 98.59%	553 $397,000
Q1 2023 May 04, 2023	SELL	$680.49 - $826.97 $3.42 Million - $4.16 Million	-5,027 Reduced 11.35%	39,246 $32.2 Million
Q4 2022 Feb 06, 2023	SELL	$705.89 - $766.39 $6.91 Million - $7.5 Million	-9,786 Reduced 18.1%	44,273 $31.9 Million
Q3 2022 Nov 02, 2022	SELL	$573.97 - $724.32 $1.87 Million - $2.36 Million	-3,260 Reduced 5.69%	54,059 $37.2 Million
Q2 2022 Aug 05, 2022	BUY	$548.35 - $738.84 $627,312 - $845,232	1,144 Added 2.04%	57,319 $33.9 Million
Q1 2022 May 06, 2022	SELL	$595.12 - $698.43 $32.6 Million - $38.2 Million	-54,720 Reduced 49.34%	56,175 $39.2 Million
Q4 2021 Feb 03, 2022	BUY	$543.48 - $670.97 $41.9 Million - $51.7 Million	77,100 Added 228.14%	110,895 $70 Million
Q3 2021 Nov 08, 2021	SELL	$574.03 - $680.96 $5.97 Million - $7.08 Million	-10,402 Reduced 23.54%	33,795 $20.5 Million
Q2 2021 Aug 05, 2021	BUY	$472.8 - $558.54 $8.77 Million - $10.4 Million	18,553 Added 72.35%	44,197 $24.7 Million
Q1 2021 May 05, 2021	BUY	$446.73 - $548.2 $9.88 Million - $12.1 Million	22,111 Added 625.84%	25,644 $12.1 Million
Q4 2020 Feb 04, 2021	SELL	$478.3 - $607.98 $3.49 Million - $4.44 Million	-7,300 Reduced 67.39%	3,533 $1.71 Million
Q3 2020 Nov 02, 2020	SELL	$544.75 - $658.21 $2.59 Million - $3.13 Million	-4,748 Reduced 30.47%	10,833 $6.06 Million
Q2 2020 Aug 05, 2020	SELL	$493.32 - $643.92 $5.44 Million - $7.1 Million	-11,028 Reduced 41.44%	15,581 $9.72 Million
Q1 2020 May 04, 2020	SELL	$336.18 - $494.43 $168,090 - $247,215	-500 Reduced 1.84%	26,609 $13 Million
Q4 2019 Feb 07, 2020	BUY	$274.13 - $376.51 $3.47 Million - $4.76 Million	12,650 Added 87.49%	27,109 $10.2 Million
Q3 2019 Nov 07, 2019	SELL	$273.46 - $318.39 $905,152 - $1.05 Million	-3,310 Reduced 18.63%	14,459 $4.01 Million
Q2 2019 Jul 29, 2019	SELL	$299.6 - $414.82 $840,078 - $1.16 Million	-2,804 Reduced 13.63%	17,769 $5.56 Million
Q1 2019 Apr 25, 2019	SELL	$372.08 - $439.57 $20.2 Million - $23.8 Million	-54,179 Reduced 72.48%	20,573 $8.45 Million
Q4 2018 Feb 11, 2019	SELL	$335.82 - $403.04 $714,624 - $857,669	-2,128 Reduced 2.77%	74,752 $27.9 Million
Q3 2018 Nov 05, 2018	SELL	$351.14 - $408.51 $3.62 Million - $4.22 Million	-10,318 Reduced 11.83%	76,880 $31.1 Million
Q2 2018 Jul 31, 2018	SELL	$284.6 - $344.99 $5.76 Million - $6.98 Million	-20,234 Reduced 18.83%	87,198 $30.1 Million
Q1 2018 Apr 27, 2018	BUY	$315.82 - $393.78 $5.14 Million - $6.41 Million	16,290 Added 17.87%	107,432 $37 Million
Q4 2017 Feb 05, 2018	BUY	$358.63 - $469.95 $25.2 Million - $33 Million	70,307 Added 337.45%	91,142 $34.3 Million
Q3 2017 Nov 06, 2017	BUY	$431.38 - $504.0 $7.27 Million - $8.49 Million	16,854 Added 423.36%	20,835 $9.32 Million
Q2 2017 Aug 09, 2017	BUY	N/A	3,981	3,981 $1.96 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History